Profil
Hoda Tawfik is a former Head of Clinical Operations & Medical Affairs at MediGene AG.
She was also a Professor at the University of Cairo.
From 2012 to 2020, she served as the Chief Medical Officer at MagForce AG.
Currently, she is the Vice President of Medical Affairs at Clinical Laserthermia Systems AB. Tawfik holds a doctorate degree from Heinrich-Heine-Universität Düsseldorf.
Anciens postes connus de Hoda Tawfik
| Sociétés | Poste | Fin |
|---|---|---|
| CLINICAL LASERTHERMIA SYSTEMS AB | Directeur Technique/Scientifique/R&D | 19/12/2023 |
| MAGFORCE AG | Directeur Technique/Scientifique/R&D | 01/10/2020 |
University of Cairo
University of Cairo Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| MEDIGENE AG | Corporate Officer/Principal | - |
Formation de Hoda Tawfik
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
MediGene AG
MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
University of Cairo
University of Cairo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heinrich-Heine-Universität Düsseldorf
Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MagForce AG
MagForce AG Medical SpecialtiesHealth Technology Operates as a medical technology company in the field of nanomedicine focusing on oncology | Health Technology |
Clinical Laserthermia Systems AB
Clinical Laserthermia Systems AB Medical SpecialtiesHealth Technology Engages in developing, manufacturing, importing and trading of equipment for medical applications and related business | Health Technology |
















